Skip to main content
Top

Journal of Thrombosis and Thrombolysis

Issue 3/2010

Content (20 Articles)

Efficacy of enoxaparin, certoparin and dalteparin in preventing cardiac catheter thrombosis: an in vitro approach

Uwe Raaz, Michael Buerke, Marese Busshardt, Lars Maegdefessel, Alexander Plehn, Baerbel Hauroeder, Karl Werdan, Axel Schlitt

Secretory phospholipase A2 in patients with coronary artery disease

Luciana Moreira Lima, Maria das Graças Carvalho, Cirilo Pereira da Fonseca Neto, José Carlos Faria Garcia, Marinez Oliveira Sousa

Frequency and safety of switching antithrombin therapy at a regional PCI center

Bina Ahmed, Colleen Thomas, Carl Kapadia, Faraz Sandhu, Sadie Mills, Faye Straight, David J. Schneider, Harold L. Dauerman

Mild hypothermia markedly reduces ischemia related coronary t-PA release

Jesper van der Pals, Matthias Götberg, Göran K. Olivecrona, Helen Brogren, Sverker Jern, David Erlinge

The clinical significance of the lack of arterial or venous thrombosis in patients with congenital prothrombin or FX deficiency

Antonio Girolami, Nicole Candeo, Silvia Vettore, Anna Maria Lombardi, Bruno Girolami

The prevalence and clinical significance of inherited thrombophilic risk factors in patients with antiphospholipid syndrome

Reyhan Diz-Kucukkaya, Veysel Sabri Hancer, Bahar Artim-Esen, Yuksel Pekcelen, Murat Inanc

Increased platelet activation in patients with slow coronary flow

Turgay Celik, U. Cagdas Yuksel, Baris Bugan, Atila Iyisoy, Murat Celik, Sait Demirkol, Halil Yaman, Hurkan Kursaklioglu, Selim Kilic, Ersoy Isik

Incidence of hemorrhage among anticoagulated patients receiving antiplatelet therapy after percutaneous coronary intervention

Kari L. Olson, Thomas Delate, Samuel G. Johnson, Erika Dawn Wilson, Daniel M. Witt

Effectiveness of enoxaparin for prevention of radial artery occlusion after transradial cardiac catheterization

Hasan Feray, Cemil Izgi, Diler Cetiner, Ebubekir Emre Men, Yelda Saltan, Ayhan Baltay, Reyhan Kahraman

Open Access

Are hospitals delivering appropriate VTE prevention? The venous thromboembolism study to assess the rate of thromboprophylaxis (VTE start)

A. Amin, A. C. Spyropoulos, P. Dobesh, A. Shorr, M. Hussein, E. Mozaffari, J. S. Benner

Thrombotic storm in Kimura disease

Hong Liu, Samer Z. Al-Quran, Richard Lottenberg

Antithrombotic therapy for ischemic stroke: guidelines translated for the clinician

Anandi Krishnan, Renato D. Lopes, John H. Alexander, Richard C. Becker, Larry B. Goldstein

Erratum

Effects of serum homocysteine and adiponectin levels on platelet aggregation in untreated patients with essential hypertension

Hakan Ekmekçi, Özlem Balcı Ekmekçi, Serap Erdine, Hüseyin Sönmez, Yusup Ataev, Zeynep Öztürk, İlknur İşler Bütün, Çiğdem Gürel, Mine Kucur, Nurver Turfaner, Turgut Ulutin, Sevim Purisa, Vural Ali Vural

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine